These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8090772)

  • 21. Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum.
    Frim DM; Short MP; Rosenberg WS; Simpson J; Breakefield XO; Isacson O
    J Neurosurg; 1993 Feb; 78(2):267-73. PubMed ID: 8421209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-brain barrier penetration and in vivo activity of an NGF conjugate.
    Friden PM; Walus LR; Watson P; Doctrow SR; Kozarich JW; Bäckman C; Bergman H; Hoffer B; Bloom F; Granholm AC
    Science; 1993 Jan; 259(5093):373-7. PubMed ID: 8420006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease.
    Ryu JK; Kim J; Cho SJ; Hatori K; Nagai A; Choi HB; Lee MC; McLarnon JG; Kim SU
    Neurobiol Dis; 2004 Jun; 16(1):68-77. PubMed ID: 15207263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer.
    Bemelmans AP; Horellou P; Pradier L; Brunet I; Colin P; Mallet J
    Hum Gene Ther; 1999 Dec; 10(18):2987-97. PubMed ID: 10609659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: implications for timing of surgical intervention.
    Watts C; Dunnett SB
    J Neurosurg; 1998 Aug; 89(2):267-74. PubMed ID: 9688122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration.
    Bazzett TJ; Becker JB; Kaatz KW; Albin RL
    Exp Neurol; 1993 Apr; 120(2):177-85. PubMed ID: 8387931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum.
    Ryu JK; Choi HB; McLarnon JG
    Neurobiol Dis; 2005 Nov; 20(2):550-61. PubMed ID: 15916899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenoviral gene delivery of pigment epithelium-derived factor protects striatal neurons from quinolinic acid-induced excitotoxicity.
    Sanagi T; Yabe T; Yamada H
    J Neuropathol Exp Neurol; 2010 Mar; 69(3):224-33. PubMed ID: 20142768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates.
    Koliatsos VE; Clatterbuck RE; Nauta HJ; Knüsel B; Burton LE; Hefti FF; Mobley WC; Price DL
    Ann Neurol; 1991 Dec; 30(6):831-40. PubMed ID: 1789695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: trophic effects upon cholinergic and noncholinergic striatal neurons.
    Kordower JH; Chen EY; Mufson EJ; Winn SR; Emerich DF
    Neuroscience; 1996 May; 72(1):63-77. PubMed ID: 8730706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity.
    Liang ZQ; Wang XX; Wang Y; Chuang DM; DiFiglia M; Chase TN; Qin ZH
    Neurobiol Dis; 2005 Nov; 20(2):562-73. PubMed ID: 15922606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid.
    Davies SW; Roberts PJ
    Nature; 1987 May 28-Jun 3; 327(6120):326-9. PubMed ID: 2884569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow mesenchymal stem cells can improve the motor function of a Huntington's disease rat model.
    Jiang Y; Lv H; Huang S; Tan H; Zhang Y; Li H
    Neurol Res; 2011 Apr; 33(3):331-7. PubMed ID: 21513650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of cognitive deficits and decreased cholinergic neuronal cell loss and apoptotic cell death following neurotrophin infusion after experimental traumatic brain injury.
    Sinson G; Perri BR; Trojanowski JQ; Flamm ES; McIntosh TK
    J Neurosurg; 1997 Mar; 86(3):511-8. PubMed ID: 9046309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective role of nerve growth factor against excitatory amino acid injury during neostriatal cholinergic neurons postnatal development.
    Pérez-Navarro E; Alberch J
    Exp Neurol; 1995 Oct; 135(2):146-52. PubMed ID: 7589325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.
    McBride JL; Behrstock SP; Chen EY; Jakel RJ; Siegel I; Svendsen CN; Kordower JH
    J Comp Neurol; 2004 Jul; 475(2):211-9. PubMed ID: 15211462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor age dependent graft development and recovery in a rat model of Huntington's disease: histological and behavioral analysis.
    Schackel S; Pauly MC; Piroth T; Nikkhah G; Döbrössy MD
    Behav Brain Res; 2013 Nov; 256():56-63. PubMed ID: 23916743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins.
    Burke MA; Mobley WC; Cho J; Wiegand SJ; Lindsay RM; Mufson EJ; Kordower JH
    Exp Neurol; 1994 Dec; 130(2):178-95. PubMed ID: 7867749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter.
    Zhang Y; Schlachetzki F; Zhang YF; Boado RJ; Pardridge WM
    Hum Gene Ther; 2004 Apr; 15(4):339-50. PubMed ID: 15053859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.